IFP Advisors, Inc - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 27 filers reported holding VASCULAR BIOGENICS LTD in Q4 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
Q4 2018$1,0000.0%8500.0%0.00%
Q3 2018$1,000
-50.0%
8500.0%0.00%
Q2 2018$2,000
-98.6%
850
-95.7%
0.00%
-100.0%
Q1 2018$139,0000.0%19,5670.0%0.01%0.0%
Q4 2017$139,000
+414.8%
19,567
+339.7%
0.01%
+500.0%
Q3 2017$27,000
-3.6%
4,450
-29.9%
0.00%0.0%
Q2 2017$28,000
-49.1%
6,350
-36.5%
0.00%
-50.0%
Q1 2017$55,000
-57.4%
10,000
-62.3%
0.00%
-66.7%
Q4 2016$129,000
-20.4%
26,550
-14.4%
0.01%
-25.0%
Q3 2016$162,000
-12.4%
31,000
-22.7%
0.01%
-20.0%
Q2 2016$185,000
+302.2%
40,100
+360.9%
0.01%
+233.3%
Q4 2015$46,0008,7000.00%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q4 2017
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 152,764$365,0000.50%
Ikarian Capital, LLC 800,811$1,915,0000.16%
DAFNA Capital Management LLC 306,980$734,0000.15%
PVG ASSET MANAGEMENT CORP 12,155$29,050,0000.09%
Phoenix Holdings Ltd. 1,060,300$2,534,0000.05%
Virtu Financial LLC 39,618$95,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 89,689$214,0000.01%
HBK Sorce Advisory LLC 22,000$53,0000.00%
MORGAN STANLEY 693,420$1,658,0000.00%
Bank of New York Mellon Corp 25,000$60,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders